Correlation Between Evoke Pharma and Shuttle Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Evoke Pharma and Shuttle Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evoke Pharma and Shuttle Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Evoke Pharma and Shuttle Pharmaceuticals, you can compare the effects of market volatilities on Evoke Pharma and Shuttle Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evoke Pharma with a short position of Shuttle Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evoke Pharma and Shuttle Pharmaceuticals.
Diversification Opportunities for Evoke Pharma and Shuttle Pharmaceuticals
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Evoke and Shuttle is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Evoke Pharma and Shuttle Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Shuttle Pharmaceuticals and Evoke Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evoke Pharma are associated (or correlated) with Shuttle Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Shuttle Pharmaceuticals has no effect on the direction of Evoke Pharma i.e., Evoke Pharma and Shuttle Pharmaceuticals go up and down completely randomly.
Pair Corralation between Evoke Pharma and Shuttle Pharmaceuticals
Given the investment horizon of 90 days Evoke Pharma is expected to generate 0.95 times more return on investment than Shuttle Pharmaceuticals. However, Evoke Pharma is 1.06 times less risky than Shuttle Pharmaceuticals. It trades about -0.01 of its potential returns per unit of risk. Shuttle Pharmaceuticals is currently generating about -0.04 per unit of risk. If you would invest 530.00 in Evoke Pharma on October 25, 2024 and sell it today you would lose (77.00) from holding Evoke Pharma or give up 14.53% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Evoke Pharma vs. Shuttle Pharmaceuticals
Performance |
| Timeline |
| Evoke Pharma |
| Shuttle Pharmaceuticals |
Evoke Pharma and Shuttle Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Evoke Pharma and Shuttle Pharmaceuticals
The main advantage of trading using opposite Evoke Pharma and Shuttle Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evoke Pharma position performs unexpectedly, Shuttle Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Shuttle Pharmaceuticals will offset losses from the drop in Shuttle Pharmaceuticals' long position.| Evoke Pharma vs. Petros Pharmaceuticals | Evoke Pharma vs. Cumberland Pharmaceuticals | Evoke Pharma vs. Painreform | Evoke Pharma vs. Aquestive Therapeutics |
| Shuttle Pharmaceuticals vs. Lifecore Biomedical | Shuttle Pharmaceuticals vs. Tilray Inc | Shuttle Pharmaceuticals vs. Organogenesis Holdings | Shuttle Pharmaceuticals vs. Journey Medical Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |